Contravisory Investment Management’s Colgate-Palmolive CL Stock Holding History

Contravisory Investment Management’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,949	Closed	-$632K	–	386
2024 Q4	$632K	Buy	6,949 +64	+0.9%	+$6.11K	0.14%	102
2024 Q3	$715K	Buy	+6,885	New	+$702K	0.15%	94
2018 Q3	–	Sell	-1,600	Closed	-$104K	–	301
2018 Q2	$104K	Hold	1,600	–	–	0.04%	195
2018 Q1	$115K	Hold	1,600	–	–	0.04%	186
2017 Q4	$121K	Hold	1,600	–	–	0.04%	182
2017 Q3	$117K	Buy	+1,600	New	+$115K	0.04%	175
2017 Q2	–	Sell	-1,600	Closed	-$117K	–	161
2017 Q1	$117K	Hold	1,600	–	–	0.04%	149
2016 Q4	$105K	Hold	1,600	–	–	0.04%	103
2016 Q3	$119K	Sell	1,600 -29	-2%	-$2.14K	0.04%	85
2016 Q2	$119K	Hold	1,629	–	–	0.04%	88
2016 Q1	$115K	Buy	1,629 +29	+2%	+$1.93K	0.03%	91
2015 Q4	$107K	Hold	1,600	–	–	0.03%	91
2015 Q3	$102K	Hold	1,600	–	–	0.02%	88
2015 Q2	$105K	Hold	1,600	–	–	0.02%	94
2015 Q1	$111K	Buy	+1,600	New	+$111K	0.02%	86
2014 Q1	–	Sell	-193,893	Closed	-$12.6M	–	156
2013 Q4	$12.6M	Sell	193,893 -1,246	-0.6%	-$79.7K	2.43%	22
2013 Q3	$11.6M	Sell	195,139 -3,025	-2%	-$179K	2.41%	24
2013 Q2	$11.4M	Buy	+198,164	New	+$11.8M	2.52%	14

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Contravisory Investment Management's CL Position: Q1 2025 in Review

Contravisory Investment Management sold out of Colgate-Palmolive (CL) in Q1 2025, closing a stake of 6,949 shares — an estimated $632K sold.

Contravisory Investment Management first reported a position in CL in Q2 2013 and held it in 18 quarters. The position peaked at $12.6M in Q4 2013. 1,948 funds tracked by Wall St. Rank hold CL as of Q1 2025.

Contravisory Investment Management reported no remaining Colgate-Palmolive position as of Q1 2025 after selling out during the quarter.
Contravisory Investment Management sold 6,949 Colgate-Palmolive shares in Q1 2025, an estimated $632K.
Contravisory Investment Management first reported a position in Colgate-Palmolive in Q2 2013 and held it in 18 quarters.
Contravisory Investment Management's Colgate-Palmolive position peaked at $12.6M in Q4 2013.
1,948 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2025.

Based on Contravisory Investment Management's 13F filing for Q1 2025, filed 10 Apr 2025.